Vivos therapeutics announces integrative cardiologist dr. mimi guarneri as new medical director of clinical education

Highlands ranch, colo., april 14, 2021 (globe newswire) -- vivos therapeutics, inc. (“the company”) (nasdaq: vvos), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (osa), today announced the appointment of mimi guarneri, md, facc as an independent consultant serving in the role of medical director of clinical education, effective april 1, 2021.
VVOS Ratings Summary
VVOS Quant Ranking